These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1371319)

  • 1. Type- and group-specific continuous antigenic determinants of HTLV. Use of synthetic peptides for serotyping of HTLV-I and -II infection.
    Blomberg J; Robert-Guroff M; Blattner WA; Pipkorn R
    J Acquir Immune Defic Syndr (1988); 1992; 5(3):294-302. PubMed ID: 1371319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serological speciation of human T-cell leukaemia virus infections using synthetic peptide antigens.
    Tosswill JH; McAlpine L; Mortimer PP
    J Med Virol; 1993 May; 40(1):83-5. PubMed ID: 8099946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological discrimination between HTLV-I and HTLV-II antibodies by ELISA using synthetic peptides as antigens.
    Washitani Y; Kuroda N; Shiraki H; Nishimura Y; Yamaguchi K; Takatsuki K; Fernando LP; Fang CT; Kiyokawa H; Maeda Y
    Int J Cancer; 1991 Sep; 49(2):173-7. PubMed ID: 1879964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of an immunoblot assay for serological confirmation and differentiation of human T-cell lymphotropic virus types I and II.
    Roberts BD; Foung SK; Lipka JJ; Kaplan JE; Hadlock KG; Reyes GR; Chan L; Heneine W; Khabbaz RF
    J Clin Microbiol; 1993 Feb; 31(2):260-4. PubMed ID: 8432811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human T-cell lymphotropic virus type 1 gag indeterminate western blot patterns in Central Africa: relationship to Plasmodium falciparum infection.
    Mahieux R; Horal P; Mauclère P; Mercereau-Puijalon O; Guillotte M; Meertens L; Murphy E; Gessain A
    J Clin Microbiol; 2000 Nov; 38(11):4049-57. PubMed ID: 11060067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced specificity of truncated transmembrane protein for serologic confirmation of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 infections by western blot (immunoblot) assay containing recombinant envelope glycoproteins.
    Varma M; Rudolph DL; Knuchel M; Switzer WM; Hadlock KG; Velligan M; Chan L; Foung SK; Lal RB
    J Clin Microbiol; 1995 Dec; 33(12):3239-44. PubMed ID: 8586709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discrimination between human T-cell lymphotropic virus type I and II (HTLV-I and HTLV-II) infections by using synthetic peptides representing an immunodominant region of the core protein (p19) of HTLV-I and HTLV-II.
    Bonis J; Baillou A; Barin F; Verdier M; Janvier B; Denis F
    J Clin Microbiol; 1993 Jun; 31(6):1481-5. PubMed ID: 8314990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of immunodominant epitopes in envelope glycoprotein of human T lymphotropic virus type II.
    Lal RB; Rudolph DL; Kaplan JE; Hjelle B; Levine PH; Coligan JE; Viscidi RP
    Virology; 1992 Jan; 186(1):274-9. PubMed ID: 1727602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serologic differentiation of human T lymphotropic virus type I from type II infection by synthetic peptide immunoassays.
    Roberts CR; Mitra R; Hyams K; Brodine SK; Lal RB
    J Med Virol; 1992 Apr; 36(4):298-302. PubMed ID: 1578221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure to detect evidence of human T-lymphotropic virus (HTLV) type I and type II in blood donors with isolated gag antibodies to HTLV-I/II.
    Lal RB; Rudolph DL; Coligan JE; Brodine SK; Roberts CR
    Blood; 1992 Jul; 80(2):544-50. PubMed ID: 1627806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a type-specific protein that differentiates serologically between human T cell lymphotropic virus types I and II.
    Carrera-Zandomeni M; Zandomeni R; Esteban EN; Ferrer JF
    J Infect Dis; 1993 May; 167(5):1021-6. PubMed ID: 8486936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and differentiation of HTLV-I and HTLV-II infection by enzyme immunoassays using synthetic peptides.
    Viscidi RP; Hill PM; Li SJ; Cerny EH; Vlahov D; Farzadegan H; Halsey N; Kelen GD; Quinn TC
    J Acquir Immune Defic Syndr (1988); 1991; 4(12):1190-8. PubMed ID: 1941526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modified Western blot assay for confirmation and differentiation of human T cell lymphotropic virus types I and II.
    Lipka JJ; Santiago P; Chan L; Reyes GR; Samuel KP; Blattner WA; Shaw GM; Hanson CV; Sninsky JJ; Foung SK
    J Infect Dis; 1991 Aug; 164(2):400-3. PubMed ID: 1856487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological and molecular evidence of infection by human T-cell lymphotropic virus type II in Italian drug addicts by use of synthetic peptides and polymerase chain reaction.
    De Rossi A; Mammano F; Del Mistro A; Chieco-Bianchi L
    Eur J Cancer; 1991; 27(7):835-8. PubMed ID: 1834112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human T lymphotropic virus types I and II proviral sequences in Argentinian blood donors with indeterminate Western blot patterns.
    Mangano AM; Remesar M; del Pozo A; Sen L
    J Med Virol; 2004 Oct; 74(2):323-7. PubMed ID: 15332282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.
    Horal P; Hall WW; Svennerholm B; Lycke J; Jeansson S; Rymo L; Kaplan MH; Vahlne A
    Proc Natl Acad Sci U S A; 1991 Jul; 88(13):5754-8. PubMed ID: 1712105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serologic discrimination of human T cell lymphotropic virus infection by using a synthetic peptide-based enzyme immunoassay.
    Lal RB; Rudolph DL; Lairmore MD; Khabbaz RF; Garfield M; Coligan JE; Folks TM
    J Infect Dis; 1991 Jan; 163(1):41-6. PubMed ID: 1984475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Evaluation of a Novel ELISA for Detection of Antibodies against HTLV-I Using Chimeric Peptides.
    Mosadeghi P; Heydari-Zarnagh H
    Iran J Allergy Asthma Immunol; 2018 Apr; 17(2):144-150. PubMed ID: 29757587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chimeric synthetic peptides from the envelope (gp46) and the transmembrane (gp21) glycoproteins for the detection of antibodies to human T-cell leukemia virus type II.
    Hernández Marin M; Castellanos Pentón P; Márquez Bocalandro Y; Pozo Peña L; Díaz Navarro J; González López LJ
    Biochem Biophys Res Commun; 2001 Nov; 289(1):7-12. PubMed ID: 11708768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory characterization of human T cell lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) infections in blood donors from Sao Paulo, Brazil.
    Segurado AA; Malaque CM; Sumita LM; Pannuti CS; Lal RB
    Am J Trop Med Hyg; 1997 Aug; 57(2):142-8. PubMed ID: 9288805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.